Comparison

ARRY-403 European Partner

Item no. TMO-T30142-500mg
Manufacturer TargetMol
CASRN 1138669-65-4
Amount 500 mg
Quantity options 100 mg 10 mg 1 mg 25 mg 500 mg 50 mg 5 mg
Category
Type Chemicals
Specific against other
Formula C20H18N6O3S2
Smiles Cc1ncccc1Oc1cc(Sc2ccccn2)cnc1Nc1nc(ns1)[C@H](O)CO
ECLASS 10.1 32160000
ECLASS 11.0 32160000
UNSPSC 12000000
Alias AMG-151,ARRY 403,ARRY403,ARRY-403,AMG151,AMG 151
Shipping Condition Cool pack
Available
Manufacturer - Targets
Glucokinase
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
454.52
Description
ARRY-403 is a novel glucokinase activator that reduces fasting and postprandial blood glucose in patients with type 2 diabetes.
Pathways
Metabolism
Bioactivity
ARRY-403 (AMG-151) is an oral allosteric glucokinase (GK) activator for the treatment of type 2 diabetes mellitus (T2DM).

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 500 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close